Literature DB >> 3176153

Visceral leishmaniasis in the Sudan: comparative parasitological methods of diagnosis.

M Siddig1, H Ghalib, D C Shillington, E A Petersen.   

Abstract

Patients with suspected kala-azar had aspirations of spleen, lymph node and bone marrow performed to compare the relative merit of each procedure. Splenic aspiration remains the method most likely to provide microscopic proof of leishmanial infection (18 of 19 samples) and was the only site positive in 5 patients. Lymph node aspirates contained parasites in 20 of 29 patients, whereas bone marrow aspirates provided the diagnosis in 18 of 28. Therefore, lymph node aspiration, with its minimal morbidity, is indicated as the primary diagnostic method in patients in the Sudan with suspected kala-azar. If negative, splenic aspiration should be performed.

Entities:  

Mesh:

Year:  1988        PMID: 3176153

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  17 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

Review 2.  Diagnosis of visceral leishmaniasis.

Authors:  Pankaj Srivastava; Anand Dayama; Sanjana Mehrotra; Shyam Sundar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-11       Impact factor: 2.184

3.  Evaluation of PCR for diagnosis of visceral leishmaniasis.

Authors:  O F Osman; L Oskam; E E Zijlstra; N C Kroon; G J Schoone; E T Khalil; A M El-Hassan; P A Kager
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Nano-structured nickel oxide based DNA biosensor for detection of visceral leishmaniasis (Kala-azar).

Authors:  Swati Mohan; Pankaj Srivastava; S N Maheshwari; Shyam Sundar; Rajiv Prakash
Journal:  Analyst       Date:  2011-05-25       Impact factor: 4.616

Review 5.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  Identification and Characterization of a Novel, 37-Kilodalton Leishmania donovani antigen for diagnosis of Indian visceral leishmaniasis.

Authors:  Subodh Kumar; Dinesh Kumar; Jaya Chakravarty; Shyam Sundar
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

7.  Performance of rK39 immunochromatography and freeze-dried direct agglutination tests in the diagnosis of imported visceral leishmaniasis.

Authors:  Amal El-Moamly; Mohamed El-Sweify; Mohamed Hafeez
Journal:  Parasitol Res       Date:  2011-06-28       Impact factor: 2.289

8.  Visceral leishmaniasis: rapid response to AmBisome treatment.

Authors:  O P Smith; I M Hann; H Cox; V Novelli
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

Review 9.  The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis.

Authors:  Gláucia Fernandes Cota; Marcos Roberto de Sousa; Fábio Nogueira Demarqui; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

10.  Developments in diagnosis and antileishmanial drugs.

Authors:  Prachi Bhargava; Rajni Singh
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.